Indegene Block Deal | 10.5% equity changes hands, CA Dawn Investments likely seller

As much as 10.5% equity of Indegene Ltd changed hands in block deals on Wednesday, June 4.

On Tuesday, June 3, CNBC-TV18 reported, citing sources that CA Dawn Investments, an affiliate of US-based Carlyle, was likely to sell a 10.2% stake in the healthcare tech firm via block deals valued at approximately ₹1,420 crore.

The transaction would involve the sale of 2.44 crore shares at a floor price of ₹580 apiece, sources said.

As per data available on the stock exchanges, CA Dawn Investments held 10.2% stake in Indegene at the end of the March quarter.

The company had previously witnessed a block deal in December 2024, where 1.13 crore shares, or 4.7% equity worth ₹707 crore had changed hands at an average of ₹623 per share. Prior to the block deal, sources had told CNBC-TV18 that CA Dawn Investments was likely to sell 2.9% stake in the company.

At the end of the September quarter, CA Dawn Investments held a 20.42% stake in the company.

Indegene Ltd listed on the stock exchanges on May 13, 2024 at a premium of 46% over the issue price of The Indegene stock listed at ₹655 on the NSE, a premium of 44.91%, while it listed at a premium of 46%, at ₹659.70 on the BSE.

Shares of Indgene Ltd ended 1.92% lower at ₹617 apiece on Tuesday, June 3. The stock has gained 10.66% in the past month.

Also Read: Dixon Technologies seeks government nod to partner with Chinese firm HKC to make display modules